Identificar de manera oportuna, a través del índice neutrófilo/linfocito, la gravedad de los pacientes con neumonía, incluida la producida por la COVID-19, para mejorar el proceso vigilancia-tratamiento hacia un éxito terapéutico.
Identify in a timely manner, through the neutrophil / lymphocyte index, the severity of patients with pneumonia, including that produced by COVID-19, to improve the surveillance-treatment process towards therapeutic success.
Che-Morales JL, Cortes-Telles A. Índice neutrófilo/linfocito como biomarcador sérico asociado con neumonía adquirida en comunidad. Rev Med Inst Mex Seguro Soc. 2018;56(6):537-43.
Wan J, Wang X, Zhen Y, Chen X, Yao P, Liu W, et al. The predictive role of the neutrophil–lymphocyte ratio in the prognosis of adult patients with stroke. Chin Neurosurg J. 2020;6:22. DOI: 10.1186/s41016-020-00201-5
Ye W, Chen G, Li X, Lan X, Ji C, Hou M, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020;21:169. DOI: 10.1186/s12931-020-01428-7
Imran MM, Ahmad U, Usman U, Ali M, Shaukat A, Gul N. Neutrophil/lymphocyte ratio- A marker of COVID-19 pneumonia severity. Int J Clin Pract. 2021;00:e13698. DOI: 10.1111/ijcp.13698
Stojkovic LM, Pavlovic MA, Stankovic S, Stojkovic M, Dimitrijevic I, Radoman IV, et al. Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer. Disease Markers. 2019;2019: 7 pages. DOI: 10.1155/2019/6036979